Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 65
Filtrer
1.
Ulster Med J ; 87(2): 83, 2018 May.
Article de Anglais | MEDLINE | ID: mdl-29867259

RÉSUMÉ

Meningococcal disease has had devastating consequences in Northern Ireland since its first description locally in 1859. The incidence of this disease has significantly declined in recent years, however it is important to understand reasons for this changing epidemiology and to acknowledge the diagnostic and clinical management developments that have been made locally. This review aims to examine the changing face of this disease in Northern Ireland over the years, with particular reference to local disease prevention, epidemiology, diagnosis, clinical treatment and management, post-disease sequelae and the role of meningitis charities locally, in terms of patient support and research.


Sujet(s)
Infections à méningocoques , Humains , Infections à méningocoques/diagnostic , Infections à méningocoques/épidémiologie , Infections à méningocoques/thérapie , Irlande du Nord
7.
Lett Appl Microbiol ; 66(4): 284-292, 2018 Apr.
Article de Anglais | MEDLINE | ID: mdl-29377174

RÉSUMÉ

In the British Isles, the frequency of rain results in the formation of puddles on footpaths and roads in/around hospitals. No data are available demonstrating the microbiological composition of such puddles and therefore a study was undertaken to examine the microbiology of puddles in the grounds of two tertiary university-teaching hospitals (18 sites) and compared with control puddles from non-hospital rural environments (eight sites), estimating (i) total viable count; (ii) identification of organisms in puddles; (iii) enumeration of Escherichia coli: (iv) detection of Extended Spectrum ß-Lactamase producing organisms and (v) direct antimicrobial susceptibility testing. A mean count of 2·3 × 103  CFU per ml and 1·0 × 109  CFU per ml was obtained for hospital and non-hospital puddles respectively. Isolates (n = 77; 54 hospital and 23 non-hospital) were isolated comprising of 23 species among 17 genera (hospital sites), where the majority (10/16; 62·5%) of genera identified were Gram-negative approximately, a fifth (20·6%) were shared by hospital and non-hospital rural samples. Escherichia coli was detected in half of the hospital puddles and under-half (37·5%) of the rural puddles extended spectrum ß-lactamase organisms were not detected in any samples examined. Rainwater puddles from the hospital and non-hospital environments contain a diverse range of bacteria, which are capable of causing infections. SIGNIFICANCE AND IMPACT OF THE STUDY: This study demonstrated the presence of a wide diversity of bacterial taxa associated with rainwater puddles around hospitals, many of which are capable of causing human disease. Of clinical significance is the presence of Pseudomonas aeruginosa isolated from a hospital puddle, particularly for patients with cystic fibrosis. The presence of potentially disease-causing bacteria in puddles in and around hospitals identifies a new potential environmental reservoir of bacteria. Furthermore work is now needed to define their potential of entering or exiting hospital wards by contaminated footwear.


Sujet(s)
Antibactériens/pharmacologie , Escherichia coli/isolement et purification , Pseudomonas aeruginosa/isolement et purification , Pluie/microbiologie , bêta-Lactamases/pharmacologie , Techniques de typage bactérien , Escherichia coli/classification , Escherichia coli/effets des médicaments et des substances chimiques , Hôpitaux d'enseignement , Hôpitaux universitaires , Humains , Tests de sensibilité microbienne , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/effets des médicaments et des substances chimiques , Royaume-Uni , Universités
9.
J Clin Pharm Ther ; 40(2): 204-7, 2015 Apr.
Article de Anglais | MEDLINE | ID: mdl-25604860

RÉSUMÉ

WHAT IS KNOWN AND OBJECTIVE: Antibiotic resistance has become a global public health issue. Most antibiotics are prescribed in the community, although there is less stewardship of such agents in the community compared to secondary and tertiary care. Few studies have attempted to examine the prescribing practices in General Practice and its impact on antibiotic resistance and, therefore, a study was performed in order to compare antibiotic susceptibilities of commensal viridans group streptococci (VGS) obtained from patient cohorts in General Practices (GP), who were high and low prescribers of oral antibiotics. METHOD: Sixty-five patients (<1 month-81 years; 77% female: 23% male) were enrolled onto the study, and viridans group streptococci (n = 5/patient) were collected from each patient's nasal passages and oropharynx region and tested for antibiotic susceptibility against (i) tetracyclines (doxycycline); (ii) macrolides (erythromycin); (iii) ß-lactams (penicillin G); and (iv) fluoroquinolones (ofloxacin & levofloxacin). RESULTS AND DISCUSSION: There were no significant differences in MICs between high and low GP prescribers with doxycycline (P = 0·094), erythromycin (P = 0·122), ofloxacin (P = 0·193) and levofloxacin (P = 0·058). However, there was a significant difference between high and low GP practices with regard to penicillin G (P = 0·031). This finding is important as the ß-lactams are the most commonly prescribed oral antibiotic in the community. WHAT IS NEW AND CONCLUSION: This study demonstrates that high prescribing practices may lead to an altered (higher) level of resistance to these agents in the commensal VGS population, which may be important as reservoirs of antibiotic resistance determinants in subsequent horizontal gene transfer events, particularly with newly colonizing pathogens, including pneumococci. Primary care physicians should be aware that increased prescribing of antibiotics may led to increased level of penicillin resistance.


Sujet(s)
Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Résistance bactérienne aux médicaments , Médecine générale/statistiques et données numériques , Infections à streptocoques/traitement médicamenteux , Streptocoques viridans , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Femelle , Fluoroquinolones/pharmacologie , Humains , Nourrisson , Nouveau-né , Macrolides/pharmacologie , Mâle , Tests de sensibilité microbienne , Adulte d'âge moyen , Types de pratiques des médecins , Tétracyclines/pharmacologie , Jeune adulte , bêta-Lactames/pharmacologie
10.
J Hosp Infect ; 89(3): 218-20, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25618235

RÉSUMÉ

A study was undertaken to compare a commercialized needle filter with a 0.2-µm filtered epidural set and a non-filtered standard needle. No culturable bacteria were detected following filtration through the 0.2-µm filter. Bacterial breakthrough was observed with the filtered needle (pore size 5 µm) and the non-filtered needle. Filtered systems (0.2 µm) should be employed to achieve total bacterial retention. This highlights that filtration systems with different pore sizes will have varying ability to retain bacteria. Healthcare professionals need to know what type/capability of filter is implied on labels used by manufacturers, and to assess whether the specification has the desired functionality to prevent bacterial translocation through needles.


Sujet(s)
Bactéries/isolement et purification , Filtration/méthodes , Aiguilles/microbiologie , Stérilisation
12.
J Clin Pharm Ther ; 39(5): 468-70, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-24912052

RÉSUMÉ

WHAT IS KNOWN AND OBJECTIVE: To date, there is no evidence to indicate the reliability of how patients self-report their own antibiotic usage in the community. Such data are fundamental in supporting antimicrobial stewardship practices, and so there is a need to determine its accuracy and reliability. COMMENT: Patients in the community (n = 476) were required to recollect their antibiotic usage in the past three months. Simultaneously, similar information was obtained by careful extraction from their respective medical notes, which was qualitatively compared with the patient's recollection. Overall, concordance was high (88·1%), but age (<20 and >80 years) and sex (female) were significant factors of reliability. WHAT IS NEW AND CONCLUSION: This study suggests that basic self-reporting of antibiotic usage amongst patients is relatively reliable, with increasing accuracy with years until 80 years. Where such information is critical, the current study can help decide who to interview and whose notes to interrogate, in the quest to obtain reliable and accurate information.


Sujet(s)
Antibactériens/usage thérapeutique , Types de pratiques des médecins/statistiques et données numériques , Autorapport , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Antibactériens/effets indésirables , Antibactériens/ressources et distribution , Enfant , Enfant d'âge préscolaire , Services de santé communautaires , Résistance bactérienne aux médicaments , Femelle , Besoins et demandes de services de santé , Humains , Nourrisson , Nouveau-né , Mâle , Adulte d'âge moyen , Irlande du Nord , Reproductibilité des résultats
14.
J Hosp Infect ; 83(3): 247-9, 2013 Mar.
Article de Anglais | MEDLINE | ID: mdl-23333146

RÉSUMÉ

Current autoclaving practices are designed to kill bacteria. Little is known about the effect of autoclaving on the integrity of bacterial genomic DNA. An experiment was performed to examine the effect of standard autoclaving on the integrity of bacterial DNA, employing polymerase chain reaction (PCR) as an indicator of DNA integrity. Amplifiable PCR signal was observed at t = 10, 20 and 30 min autoclaving time for Pseudomonas aeruginosa NCTC 10662; at t = 10, 20, 30 and 40 min for Salmonella Nottingham NCTC 7832; and at t = 10 and 20 min for Escherichia coli NCTC 9001. Careful consideration should therefore be given to residual molecular artefacts in future risk and environmental impact assessments, where the legacy of residual genomic DNA from dead bacterial and higher organisms may act as a potential reservoir, thereby feeding horizontal gene transfer scenarios in viable cells with potential hazardous genes of virulence, persistence or antibiotic resistance characteristics.


Sujet(s)
ADN bactérien/effets des radiations , Escherichia coli/génétique , Transfert horizontal de gène/effets des radiations , Élimination des déchets médicaux/méthodes , Pseudomonas aeruginosa/génétique , Salmonella/génétique , Stérilisation/méthodes , ADN bactérien/génétique , Escherichia coli/effets des radiations , Température élevée , Humains , Réaction de polymérisation en chaîne , Pseudomonas aeruginosa/effets des radiations , Salmonella/effets des radiations , Facteurs temps
16.
Br J Biomed Sci ; 69(3): 123-5, 2012.
Article de Anglais | MEDLINE | ID: mdl-23057160

RÉSUMÉ

Streptococcus pneumoniae is the leading cause of community-acquired pneumonia (CAP). Currently, empirical treatment with quinolones is being used due to the emergence of beta-lactam and macrolide resistance in S. pneumonaie. Although the prevalence of quinolone-resistant S. pneumoniae remains low, increasing numbers of resistant isolates are being seen. Genetic mechanisms leading to fluoroquinolone resistance in pneumococci are complex. This study aims to use molecular methods to characterise all isolates through sequence analysis of their QRDR regions. Thirty-two S. pneumoniae isolates were obtained from nasal swabs from adult and paediatric patients attending local general practices in Northern Ireland. Phenotypic minimum inhibitory concentration (MIC) was determined for Clinical and Laboratory Standards Institute (CLSI) broth microdilution against ciprofloxacin, levofloxacin and norfloxacin. Simultaneously, the QRDR regions of gyrA, gyrB, parC and parE were analysed by sequence typing for all pneumococci obtained. Only one isolate (3.1%) showed reduced susceptibility to ciprofloxacin and levofloxacin. Two amino acid positions were discordant in the S. pneumoniae R6 strain and eight (25%) and 23 (71.9%) isolates contained the mutations Ile460Val in gyrA and Lys137Asn in parC (deposited in GenBank, accession numbers GQ999587-GQ999589), respectively. No mutations were found in either the gyrB or parE loci. In conclusion, the study demonstrated increased fluoroquinolone resistance which could not be accounted for simply through QRDR mutations, and, reciprocally, that mutations in the QRDR region do not necessarily result in overt phenotypic resistance.


Sujet(s)
DNA gyrase/génétique , DNA topoisomerase IV/génétique , Résistance bactérienne aux médicaments/génétique , Quinolinone/pharmacologie , Streptococcus pneumoniae/génétique , Adulte , Survie cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/génétique , Enfant , Résistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Humains , Tests de sensibilité microbienne , Mutation , Streptococcus pneumoniae/effets des médicaments et des substances chimiques
17.
Br J Biomed Sci ; 69(3): 119-22, 2012.
Article de Anglais | MEDLINE | ID: mdl-23057159

RÉSUMÉ

Inadvertent exposure of bacterial pathogens to X-ray radiation may be an environmental stress, where the bacterium may respond by increasing mutational events, thereby potentially resulting in increased antibiotic resistance and alteration to genotypic profile. In order to examine this, four clinical pathogens, including the Gram-negative organisms Escherichia coli O157:H7 NCTC12900 and Pseudomonas aeruginosa NCTC10662, as well as the Gram-positive organisms Staphylococcus aureus NCTC6571 and Enterococcus faecium were exposed to X-rays (35,495 cGy/cm2) over a seven-day period. Antibiotic susceptibility was assessed before, during and after exposure by examining susceptibility, as quantified by E-test with six antibiotics, as well as to a further 11 antibiotics by measurement of susceptibility zone sizes (mm). Additionally, the DNA profile of each organism was compared before, during and after exposure employing the enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC PCR). Results indicated that exposure of these organisms to this amount of X-ray radiation did not alter their antibiotic susceptibility, nor their genomic DNA profile. Overall, these data indicate that exposure of bacteria to X-ray radiation does not alter the test organisms' antibiotic susceptibility profiles, nor alter genomic DNA profiles of bacteria, which therefore does not compromise molecular epidemiological tracking of bacteria within healthcare environments in which patients have been exposed to X-ray radiation.


Sujet(s)
Antibactériens/pharmacologie , Bactéries/génétique , Bactéries/effets des radiations , ADN bactérien/génétique , ADN bactérien/effets des radiations , Résistance bactérienne aux médicaments/génétique , Résistance bactérienne aux médicaments/effets des radiations , Bactéries/effets des médicaments et des substances chimiques , Relation dose-effet des rayonnements , Génotype , Mutation/génétique , Mutation/effets des radiations , Dose de rayonnement
20.
Br J Biomed Sci ; 69(1): 14-7, 2012.
Article de Anglais | MEDLINE | ID: mdl-22558799

RÉSUMÉ

Although about 75-80% of neutropenic fevers are thought to be caused by infections, a causal organism can be confirmed microbiologically or suspected clinically in only 30-50%, and even fewer of these cases (16%) have a documented bacteraemia. The cause of neutropenic fever in the remaining cases remains elusive. The reasons for this failure may be due to the difficulty in recovering low numbers of organisms, fastidious organisms which fail to grow using conventional culture media, the presence of non-culturable organisms, or the presence of inhibitory substances in specimens. Previously, the authors showed the presence of Acinetobacter in peripheral blood of febrile neutropenic patients with a haematological malignancy, using 16S rDNA polymerase chain reaction (PCR) and sequencing techniques. However, conventional culture was unable to detect these organisms. Hence, it was felt necessary to examine the antibacterial properties of four antineoplastic agents used in the treatment of haematological malignancy, namely bleomycin, cisplatin, doxorubicin and vincristine. A total of 56 wild-type Acinetobacter including seven species (A. calcoaceticus [n=17], A. septicus [n=11], A. baumannii [n=10], A. johnsonii [n=7], A. lwoffii [n=8] A. haemolyticus [n=2] and A. radioresistens [n=1]) were examined for their susceptibility to the four antineoplastic agents at therapeutic concentration. No inhibition was observed, but inhibition was seen at higher concentrations of both bleomycin and doxorubicin. Time to detection of blood culture bottles containing separate antineoplastic agents (i.e., bleomycin and doxorubicin) was compared to that containing saline using a paired t-test. Samples containing doxorubicin at 1 pg/mL were shown to have a mean time to detection of 21.8 h (range: 15.6-31.4 h). Bottles containing saline had a mean time to detection of 22.9 h (range: 18.2-31.3 h). Statistical analysis showed no significant difference (P=0.3361) between time to detection for blood culture bottles containing doxorubicin at achievable plasma concentration and corresponding negative controls. With regard to bleomycin (300 miu/mL), the mean time to detection was 27.29 h (range: 20.2-38.4 h) in the test bottles, with mean time to detection in the saline negative controls of 22.56 h (range: 17.0-30.1 h). Paired t-test gave P=0.000451, hence a significant difference in time to detection for blood cultures containing therapeutic levels of bleomycin. Overall, the antineoplastic agents vincristine, cisplatin or doxorubicin did not have any inhibitory effects on the Acinetobacter organisms examined. At worst, therapeutic concentrations of bleomycin may delay automated detection of an Acinetobacter bacteraemia by a mean time of 5.9 h.


Sujet(s)
Acinetobacter/effets des médicaments et des substances chimiques , Antibactériens/pharmacologie , Antinéoplasiques/pharmacologie , Antinéoplasiques/usage thérapeutique , Tumeurs hématologiques/traitement médicamenteux , Acinetobacter/classification , Adulte , Antibiotiques antinéoplasiques/pharmacologie , Bactériémie/diagnostic , Bactériémie/microbiologie , Bléomycine/pharmacologie , Cisplatine/pharmacologie , Techniques de laboratoire clinique , Doxorubicine/pharmacologie , Tumeurs hématologiques/sang , Humains , Tests de sensibilité microbienne , Vincristine/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...